RAYZEBIO INC (RYZB) Stock Price, Quote, News and Overview
NASDAQ:RYZB - Nasdaq - US75525N1072 - Common Stock - Currency: USD
RYZB Quote, Performance and Key Statistics
62.49
+0.01 (+0.02%)
The current stock price of RYZB is 62.49 USD. In the past month the price increased by 0.66%.
RYZB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.81 | 301.01B | ||
| AMGN | AMGEN INC | 13.81 | 147.14B | ||
| GILD | GILEAD SCIENCES INC | 22.63 | 130.06B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1646.62 | 122.76B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.3 | 61.38B | ||
| ARGX | ARGENX SE - ADR | 320.27 | 36.37B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 30.28B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.70B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.47B | ||
| NTRA | NATERA INC | N/A | 19.23B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.60B | ||
| BIIB | BIOGEN INC | 7.07 | 17.05B |
Related stock screener links
About RYZB
Company Profile
RayzeBio Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California. The company went IPO on 2023-09-15. RayzeBio, Inc. is a vertically integrated radiopharmaceutical therapeutics company. The firm is focused on building a somatostatin receptor type 2 (SSTR2) franchise. The firm's drug candidate, RYZ101, is designed to deliver a highly potent alpha particle radioisotope, Actinium 225 (Ac225), to tumors overexpressing SSTR2. RYZ101 consists of DOTATATE, a peptide binder, and a chelator, bound to Ac225, an alpha particle radioisotope. In addition to its SSTR2 franchise, the Company has discovered a peptide that selectively binds to Glypican-3 (GPC3), an oncofetal protein selectively overexpressed in hepatocellular carcinoma (HCC) as well as other cancers. The firm is enrolled in a registrational Phase III clinical trial of RYZ101 for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs) in patients who have experienced progression of their cancer following treatment with Lu177 therapy.
Company Info
RAYZEBIO INC
5505 Morehouse Drive, Suite 300
San Diego CALIFORNIA US
Employees: 88
Company Website: https://rayzebio.com/
Phone: 16199372754
RAYZEBIO INC / RYZB FAQ
What is the stock price of RAYZEBIO INC today?
The current stock price of RYZB is 62.49 USD. The price increased by 0.02% in the last trading session.
What is the ticker symbol for RAYZEBIO INC stock?
The exchange symbol of RAYZEBIO INC is RYZB and it is listed on the Nasdaq exchange.
On which exchange is RYZB stock listed?
RYZB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for RAYZEBIO INC stock?
11 analysts have analysed RYZB and the average price target is 54.4 USD. This implies a price decrease of -12.95% is expected in the next year compared to the current price of 62.49. Check the RAYZEBIO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is RAYZEBIO INC worth?
RAYZEBIO INC (RYZB) has a market capitalization of 3.81B USD. This makes RYZB a Mid Cap stock.
How many employees does RAYZEBIO INC have?
RAYZEBIO INC (RYZB) currently has 88 employees.
What are the support and resistance levels for RAYZEBIO INC (RYZB) stock?
RAYZEBIO INC (RYZB) has a support level at 62.43 and a resistance level at 62.5. Check the full technical report for a detailed analysis of RYZB support and resistance levels.
Should I buy RAYZEBIO INC (RYZB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RYZB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RYZB, evaluating the profitability, health, valuation and growth aspects
- RAYZEBIO INC (RYZB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RAYZEBIO INC (RYZB) Sales and EPS estimates to see what analysts future expectations are.
- RAYZEBIO INC (RYZB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RAYZEBIO INC (RYZB) Insider and Institutional Ownership to learn about the owners and their transactions.
- RAYZEBIO INC (RYZB) Stock Chart to make your own analysis
- RAYZEBIO INC (RYZB) Latest news and press-releases to stay up to date.
Does RAYZEBIO INC (RYZB) stock pay dividends?
RYZB does not pay a dividend.
What is the Price/Earnings (PE) ratio of RAYZEBIO INC (RYZB)?
RAYZEBIO INC (RYZB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.32).
RYZB Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to RYZB.
RYZB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RYZB. No worries on liquidiy or solvency for RYZB as it has an excellent financial health rating, but there are worries on the profitability.
RYZB Financial Highlights
Over the last trailing twelve months RYZB reported a non-GAAP Earnings per Share(EPS) of -1.32. The EPS decreased by -29.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.12% | ||
| ROE | -12.71% | ||
| Debt/Equity | 0 |
RYZB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to RYZB. The Buy consensus is the average rating of analysts ratings from 11 analysts.